Topic: Biology

Researchers in China developed a new method to produce natural killer cells that can help fight cancer. These cells are like superheroes that detect and destroy abnormal cells. The new approach is more efficient, cheaper, and faster than previous methods.

Cancer is a major health concern worldwide. Scientists have been working on ways to use the body's immune system to fight cancer. One type of cell called natural killer (NK) cells plays a crucial role in this fight. NK cells can detect and destroy abnormal cells, making them an attractive tool for cancer treatment.

Traditionally, scientists have used mature NK cells collected from sources like blood or cord blood. However, this method has several limitations, including variability between cells, limited efficiency during genetic modification, high production costs, and lengthy preparation times.

A team led by Prof. WANG Jinyong at the Institute of Zoology of the Chinese Academy of Sciences developed a different approach. Instead of modifying mature NK cells, they started with CD34+ hematopoietic stem and progenitor cells (HSPCs) taken from cord blood. From these early-stage cells, they generated induced (lab-generated) NK (iNK) cells as well as CAR-engineered iNK (CAR-iNK) cells.

The team used a three-step process to generate the iNK or CAR-iNK cells. First, they expanded CD34+ HSPCs with the help of irradiated AFT024 feeder cells. Next, the expanded cells were cultured with OP9 feeder cells to create artificial hematopoietic organoid aggregates. Finally, the cells that had committed to becoming NK cells were allowed to mature and multiply further.

This process produced highly pure iNK or CAR-iNK cells that expressed endogenous CD16. The team found that a single CD34+ HSPC could generate as many as 14 million iNK cells or 7.6 million CAR-iNK cells. This is a significant improvement over previous methods, which often required large amounts of viral vector for genetic modification.

The researchers tested the effectiveness of their new approach in laboratory models of human B-cell acute lymphoblastic leukemia (B-ALL). The results showed that both iNK and CAR-iNK cells demonstrated powerful tumor-killing ability. This new approach not only improves the efficiency of producing iNK and CAR-iNK cells but also significantly lowers the cost of CAR engineering.

The work was supported by the Ministry of Science and Technology of the People's Republic of China and the National Natural Science Foundation of China, along with other funding sources.

Why It Matters

This breakthrough has the potential to make cancer treatment more effective and accessible in India. As the country's population ages and cancer cases rise, innovative approaches like this one can help save lives.

Key Facts

• Scientists developed a new method to produce natural killer cells that can fight cancer
• The new approach uses stem cells from cord blood instead of mature NK cells
• A single CD34+ HSPC can generate up to 14 million iNK cells or 7.6 million CAR-iNK cells
• This method is more efficient, cheaper, and faster than previous methods
• The researchers tested the effectiveness of their approach in laboratory models of human B-cell acute lymphoblastic leukemia (B-ALL)

Key Terms

CAR-NK therapy

A type of cancer treatment that uses natural killer cells equipped with a lab-designed receptor to recognize and destroy cancer cells

Implications

This breakthrough has the potential to make cancer treatment more effective and accessible in India. As the country's population ages and cancer cases rise, innovative approaches like this one can help save lives.